|
|
|
Corporate Profile: OXiGENE
| Summary: |
| OXiGENE is focused on the discovery and development of therapeutics for patients with cancer and sight-threatening eye diseases and conditions. |
| Address (HQ): |
701 Gateway Blvd
Suite 210
South San Francisco, CA 94080 |
| Phone
#'s (HQ): |
| Main |
(650) 635-7000 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(650) 635-7001 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| OXGN |
| Internet
job postings: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
